Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA. ...

While a recent head-to-head trial of the obesity med heavyweights Wegovy and Zepbound favored the latter drug from Eli Lilly ...

President Trump urged pharmaceutical companies to publicly prove that their Covid-19 products work, saying in a Truth Social ...

Adults with type 1 diabetes and obesity using tirzepatide in a real-world setting had improvements in glycemic control and a reduction in body weight at 6 months, researchers reported. Tirzepatide ...

Novo Nordisk’s Wegovy has been on a winning streak as of late, with a metabolic dysfunction-associated steatohepatitis approval last month and prime position in the oral obesity race.

With one in four British adults now obese, patients worry that soaring costs of Mounjaro, driven by pressure from Trump, risk undoing life-changing progress.

Novo Nordisk's Wegovy cut cardiovascular risks significantly versus tirzepatide in a real-world study, showing fewer heart attacks, strokes, and deaths.

Some Chinese companies now racing to make generic versions of Novo Nordisk's Wegovy also supplied ingredients for more than a billion makeshift doses of weight-loss drugs sold online in the U.S. over ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for multiple health conditions.

Christina Parfitt is wanted in connection with an investigation into the sale of fake Wegovy, Mounjaro and retatrutide.

Treatment with the anti-obesity medications can reduce health risks for patients with heart failure by more than 40%. These ...